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Abstract
In the present study, we have identified the expression of adenylyl cyclase (AC) isoforms in rat neutrophils according to the mRNA
analysis and the distinct mode of regulation of isoform activity. Agarose gel electrophoresis of reverse transcription-polymerase chain
reaction (RT-PCR)-amplified products resulted in a single band of the expected size for each product with nucleotide sequences
corresponding to AC1 to AC9. AC1 was abundant, while AC2, 6 and 9 were of moderate expression among the AC isoforms in neutrophils
based on the quantitative real-time RT-PCR analysis. Exposure of neutrophils to Ca2 + ionophore A23187, isoproterenol and forskolin
stimulated cellular cyclic AMP accumulation. EDTA and the calmodulin (CaM) antagonist, trifluoperazine, prevented the A23187-induced
response. Pretreatment with pertussis toxin (PTX) inhibited the a2-adrenergic agonist, UK14304-induced cellular cyclic AMP elevation. In
addition, UK14304 augmented the cyclic AMP elevation when cells were stimulated by isoproterenol. Phorbol 12-myristate 13-acetate
(PMA) attenuated the augmentation response of UK14304 and isoproterenol. Treatment of the membrane preparations from rat neutrophils
with Ca2 +/CaM, forskolin, isoproterenol, GTPgS or Ghg all increased cyclic AMP production. The addition of protein kinase C (PKC)
catalytic fragment and Ghg augmented the Ca2 +/CaM- and isoproterenol-stimulated AC activity, respectively. However, forskolin and the
activated protein kinase A (PKA) attenuated the GTPgS- and isoproterenol-stimulated AC activity, respectively. KT5720, a PKA inhibitor,
reversed the inhibition by PKA. Taken together, these data suggest the presence of four groups of AC isoforms in rat neutrophils.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cyclic AMP, a well-known second messenger, is pro-
duced from ATP in response to the activation of adenylyl
cyclase (AC) and mediates short- and long-term physiolog-
ical effects. AC is expressed in virtually all mammalian
tissue and is regulated by hormones, neurotransmitters and
other regulatory molecules through the interaction with G
protein-coupled receptors. In general, AC consists of a short
amino-terminal region and two cytoplasmic domains (C1
and C2) separated by two six-transmembrane spans hydro-
phobic domains (M1 and M2) [1]. The C1 and C2 domains
constitute the AC catalytic machinery and are the targets for
most known intracellular regulators. A recent report indicted
that the membrane domains may also be implicated in AC
regulation [2]. At least nine separate AC isoforms have been
identified, which may be allocated into one of the four
groups according to their modes of regulation, as reviewed
by Hanoune et al. [3]. Group 1 AC isoforms (AC1, 3 and 8)
are stimulated by Ca2 + and calmodulin (CaM), while group
2 isoforms (AC2, 4 and 7) are activated by Ghg and by
protein kinase C (PKC) phosphorylation. Group 3 AC
isoforms (AC5 and 6) are inhibited by protein kinase A
(PKA) phosphorylation, while the single group 4 isoform
(AC9) is a Ca2 +/calcineurin-inhibited AC [4].
Neutrophils play a crucial role in host defense against
invading microorganisms. The increase in cellular cyclic
AMP level in neutrophils in response to a wide range of
cyclic AMP-elevating agents is associated with a modulator
effect on several neutrophil functions including adhesion
[5], chemotaxis [6] and respiratory burst [7]. However, the
AC isoforms expressed in neutrophils have not been iden-
tified. Previous studies on the AC present in neutrophils
have concentrated on the characterization of regulation of
AC activity. In the present study, we attempted to identify
the expression of AC isoforms in rat neutrophils. Using
pharmacological assay and reverse transcription-polymerase
chain reaction (RT-PCR) analysis, rat neutrophil was shown
to contain AC activity and mRNA encoding four groups of
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AC isoforms. The lack of specific anti-AC antibodies did
not allow us to correlate those data with the protein
expression of individual AC isoforms.
2. Materials and methods
2.1. Materials
Dextran T-500 and cyclic AMP enzyme immunoassay kit
were purchased from Amersham Pharmacia Biotech
(Uppsala, Sweden). Hanks’ balanced salt solution (HBSS)
was obtained from Gibco Life Technologies (Gaithersburg,
MD). PKC catalytic fragment was obtained from Biomol
Research Laboratories (Plymouth Meeting, PA). Calmodu-
lin and Ghg were purchased from Calbiochem–Novabio-
chem Co. (San Diego, CA). 5-Bromo-N-(4,5-dihydro-1H-
imidazole-2-yl)-6-quinoxalinamine (UK14304)was obtained
from Research Biochemicals International (Natick, MA). Ex
Taq DNA polymerase was obtained from TaKaRa Shuzo
(Shiga, Japan). SuperScript II RNase H reverse transcrip-
tase and RNaseOUT recombinant ribonuclease inhibitor
were purchased from Invitrogen (Carlsbad, CA). PCR Preps
DNA purification system was obtained from Promega
(Madison, WI). LightCycler-DNA Master SYBR Green I
was obtained from Roche (Mannheim, Germany). Other
chemicals were purchased from Sigma (St. Louis, MO). The
final percentage of dimethylsulfoxide (DMSO) in the reac-
tion mixture was V 0.5% (v/v).
2.2. Isolation of neutrophils
Neutrophils were isolated from pentobarbital-anesthe-
tized Sprague–Dawley rats as previously described [8].
Briefly, fresh whole blood was withdrawn from the abdomi-
nal aorta and mixed with EDTA. The neutrophils were
purified by dextran sedimentation followed by centrifuga-
tion through Ficoll-Hypaque and hypotonic lysis of eryth-
rocytes. Purified neutrophils containing >95% viable cells
(assessed by trypan blue exclusion) were resuspended in
HBSS containing 10 mM HEPES (pH 7.4) and 4 mM
NaHCO3, and kept in an ice bath before use.
2.3. Isolation of RNA
Neutrophils (5 107 cells/ml) in cold solution A (4 M
guanidium thiocyanate, 0.5% (w/v) Sarcosyl, 25 mM
sodium citrate, pH, 7.0, 0.1 M 2-mercaptoethanol) was
homogenized, and then centrifuged at 10,000 g for 10
min at 4 jC. The supernatant (per milliliter) was mixed with
0.1 ml of 2 M sodium acetate buffer, pH 5.2, 1 ml of phenol,
and 0.2 ml of CHCl3/isoamyl alcohol (49:1), then kept on
ice for 20 min. After centrifugation at 10,000 g for 20 min
at 4 jC, the aqueous phase was removed and mixed with 2
ml each of phenol and CHCl3/isoamyl alcohol, kept on ice
for 20 min followed by centrifugation at 10,000 g for 20
min at 4 jC. The supernatant was mixed with equal volume
of cold 100% isopropanol. The RNA pellet was collected
after centrifugation at 10,000 g for 10 min at 4 jC,
washed with 75% ethanol, dried in air, then dissolved in
diethyl pyrocarbonate-treated H2O and stored at  70 jC
for further analysis.
2.4. RT-PCR amplification and electrophoresis of products
Total RNA from neutrophils was used as templates for
cDNA synthesis. The reaction mixture contained 5 Ag of
total RNA, 0.5 Ag of oligo-p(dT)15, 0.83 mM deoxynu-
cleoside triphosphates (dNTPs), and adjusted volume to 12 Al
with H2O, then heated to 65 jC for 5 min. After centriofu-
gation, the pellet was collected, mixed with 10 mM dithio-
threitol, 2 units/Al of RNaseOUT recombinant ribonuclease
inhibitor, and 10 units/Al of SuperScript II RNase H reverse
transcriptase. Annealing and primer extension were per-
formed at 42 jC for 1 h. PCR amplifications were per-
formed in a final volume of 25 Al, containing 1 Al of
cDNA, 0.65 units of Ex Taq DNA polymerase, 0.25 mM
dNTPs and 0.5 AM of each specific primer. Ten pairs of
the following single-stranded oligodeoxynucleotide
primers were synthesized: forward 5V-ACCAGCCAAGAG-
GATGAAGTT-3V and reverse 5V-ATACCAGCAGCAG-
CAGGACAG-3V for the 446-bp mouse AC1 [9]; forward
5V-GGGAAGATTAGTACCACGGAT-3Vand reverse 5V-AG-
GAGAAGCCAAGGATGGACG-3Vfor the 334-bp rat AC2
[10]; forward 5V-ATGAGCACGAACTGAACCAGCT-3V
and reverse 5V-GTCCCATGTAGTACTGGAGACAGCTC-3V
for the 456-bp rat AC3 [11]; forward 5V-AGCCAG-
CCTACCCAGGTT-3V and reverse 5V-GCTTGGGTCT-
GAGGTCA-3V for the 283-bp rat AC4 [12]; forward 5V-
CAGAGAACCAACTCCATTGGACACAATCCG-3V and
reverse 5V-CACACAGGCGTAGATCACAGATATTTT-
CAC-3V for the 456-bp rat AC5 [13]; forward 5V-TG-
CTGCTGGTCACCGTGCTCAT-3V and reverse 5V-
GGACGCTAAGCAGTAGATCATAGTTGTCAA-3V for
the 495-bp rat AC6 [13]; forward 5V-GCTCCTACT-
GAAGCCCAAGTTC-3Vand reverse 5V-AATCACTCCAG-
CAATCACAGGC-3Vfor the 256-bp rat AC7 [14]; forward
5V-CAGTCTGGGCCTGAGGAAATT-3V and reverse 5V-
AAGTCAGGTTCTTCAAGGGTA-3Vfor the 478-bp mouse
AC8 [11 ] ; f o rwa rd 5V-ACCTACCTTTACCCA-
AAGTGCACGGACAAT-3V and reverse 5V-CTCGGC-
GCTGCCTCACACACTCTTTGAGAC-3V for the 360-bp
rat AC9 [15]; forward 5V-TATGACAACTCCCTCAAGAT-
3V and reverse 5V-AGATCCACAACGGATACATT-3V for
the 317-bp rat GAPDH. The cycling conditions were
the following: 28 cycles of 0.5 min at 95 jC, 0.5 min at
58 jC, and 0.5 min at 72 jC, starting with 5 min at 95
jC and ending with 7 min at 72 jC. The resulting PCR
products obtained from the amplification reaction were
resolved using a 2.2% agarose gel, and the DNA bands
were visualized by ethidium bromide staining and sub-
sequent UV illumination. The sequences of the PCR
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products obtained from the amplification reaction were
confirmed using a CEQ 2000 capillary sequencer (Bech-
man Coulter) with Dye Terminator Cycle Sequencing kit.
2.5. Real-time quantitative RT-PCR
PCR amplification using a LightCycler instrument
(Roche) was carried out in 20 Al of reaction mixture in
microcapillary tubes. The reaction components were 1 Al of
cDNA, 1 LightCycler-DNA Master SYBR Green I, a
final concentration of 3.5 mM MgCl2 and 0.5 AM of each
primer [16]. The reactions were incubated at 95 jC (30 s)
followed by 45 cycles of amplification at 95 jC (0 s) for
denaturation, 58 jC (0 s) for annealing and 72 jC (20 s) for
extension, with fluorescence detection after each cycle.
After cycling, melting curves of the PCR products were
acquired by stepwise increase of the temperature from 65 to
98 jC. Ten-fold serial dilutions of purified PCR products
(10 1 to 105 pg/ml) were used as standards with each run.
The results are expressed as fold of induction in comparison
with the level of GAPDH mRNA.
2.6. Measurement of cyclic AMP
Neutrophils (2 106 cells/ml) were treated with test
drugs. The reaction mixture was then added to 0.05 M
acetate buffer (pH 6.2) containing 50 AM 3-isobutyl-1-
methylxanthine. After being boiled for 5 min, the suspension
was sonicated and then sedimented. Supernatants were
acetylated by the addition of 0.025 volume of triethyl-
amine/acetic anhydride (2:1, v/v). The cyclic AMP contents
of the aliquots were assayed using an enzyme immunoassay
kit.
For AC assay, cells (5 107 cells/ml) were suspended
in ice-cold Tris buffer (pH 7.4) containing 25 mM Tris,
0.25 M sucrose, 100 AM phenylmethylsulfonyl fluoride, 5
mM dithiothreitol, 10 AM each of leupeptin and pepstatin,
then sonicated, followed by centrifugation at 1000 g for
10 min at 4 jC [17]. The supernatants were centrifuged at
40,000 g for 30 min. The pellets were resuspended in
ice-cold Tris buffer and centrifuged again. The final pellet
(membrane fraction) was collected as the AC source. AC
activity was assessed by determining the cyclic AMP
levels in the reaction mixture containing 10 mM MgCl2,
7.5 mM creatine phosphate, 30 units/ml of creatine phos-
phokinase, 0.2 mM 3-isobutyl-1-methylxanthine, 1 mM
dithiothreitol, 0.2 mM ATP and membrane fraction
(2 106 cells/ml eq.) in 30 mM Tris buffer (pH 7.4) at
37 jC for 10 min.
2.7. Statistical analysis
Statistical analyses were performed using the Bonferroni
t-test method after one-way analysis of variance. A P value
< 0.05 was considered significant for all tests. Data are
expressed as meansF S.E.
3. Results and discussion
3.1. Determination of AC isoforms mRNA
To determine the AC isoforms expression in rat neutro-
phils, RT-PCR was performed with primers designed to
amplify the cDNA of AC isoforms. Ten pairs of primers,
namely those complementary to AC1 to AC9, and GAPDH
(as an internal standard) produced a single PCR product
band of the expected size for each product in agarose gel
electrophoresis (Fig. 1). Comparison of sequences obtained
with the GenBank sequences (data not shown) demonstrated
100%, 99.4%, 99.1%, 98.7%, 98.2%, 99.4% and 99.7%
identity between PCR products and the published rat AC2,
3, 4, 5, 6, 7 and 8, respectively. The corresponding sequen-
ces showed 92.8% and 90.8% identity between PCR prod-
ucts and the published mouse AC1 and AC9 sequences,
respectively. RT-PCR showed the presence of mRNA;
whether the protein is expressed to any significant extent
is not known yet because the antibodies for specific AC
isoforms are not available. LightCycler real-time PCR
technology is a sensitive and rapid method for quantitative
determination of gene expression [16]. The levels of AC
isoforms were shown in Fig. 1. AC1 was abundant, while
AC2, 6 and 9 were of moderate expression in neutrophils. A
single cell can express multiple AC isoforms, implying that
each isoform may serve distinct cellular activities. Never-
theless, the functional role of this diversity in neutrophils
remains unknown. To evaluate how a single AC isoform
contributes to a particular biological function is difficult to
approach in neutrophils. Because the small molecule inhib-
itors of the specific AC isoforms are not available so far, and
because the neutrophils have a short life span, we are unable
Fig. 1. Expression and quantitation of neutrophil AC isoforms mRNA.
Total mRNA was extracted from neutrophils. The agarose gel electro-
phoresis of RT-PCR products (inset) and the quantitative analysis in
comparison with GAPDH using real-time RT-PCR and SYBR Green I
detection are shown. Results presented are representative of three
independent experiments with similar results.
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to conduct the experiment of transfection with the specific
antisense.
3.2. Determination of cellular AC activity
Awide range of agonists, including h-adrenergic agents,
is known to activate Gs-coupled receptors which in turn
activates AC and elevates intracellular cyclic AMP. In
general, all of the cloned mammalian AC isoforms is
stimulated by Gs in vitro [18]. However, not all of them
are stimulated in response to the activation of Gs-coupled
receptors in vivo [19,20]. The cytoplasmic C2 domain of AC
contains the major binding site for Gsa [21]. Forskolin, a
natural diterpene, stimulates the activity of all AC isoforms
except AC9 [22] by occupying a narrow hydrophobic
crevice between C1 and C2 [23]. Incubation of the rat
neutrophils with Ca2 + ionophore A23187 (0.1 AM) caused
a three-fold rise in cyclic AMP levels at 1 min after
stimulation, which represented the peak response. It then
progressively declined (Fig. 2). The results are consistent
with the kinetics of cyclic AMP elevation by A23187 in
human and guinea pig neutrophils [24,25]. Unlike the
A23187-induced response, cellular cyclic AMP levels grad-
ually increase with the time of exposure to forskolin (10
AM) and isoproterenol (1 AM), a h-adrenoceptor agonist.
These results reveal the existence of functional AC in rat
neutrophils.
3.3. Group 1 AC isoforms activity
Pretreatment of cells with EDTA, to deplete the medium
Ca2 +, or trifluoperazine, a CaM antagonist, abolished the
A23187-induced response (Fig. 3). These results confirm
earlier observations in human and guinea pig neutrophils
[24,25] and suggest the presence of Ca2 +/CaM-sensitive
AC isoforms in rat neutrophils. The cytoplasmic C1 do-
main of AC is the site of regulation by Ca2 + and CaM
[26].
AC catalytic activity can be regulated through protein-
kinase-mediated phosphorylation. The cytoplasmic C2
domain of AC is the site of phosphorylation by PKC
[27]. In line with the previous report in human neutro-
phils [28], exposure to phorbol 12-myristate 13-acetate
(PMA), the PKC activator, induced cyclic AMP accumu-
lation in rat neutrophils (P < 0.01). In addition, PMA
markedly enhanced the responsiveness of A23187. The
action of a combination of PMA with A23187 was atten-
uated by the protein kinase inhibitor, staurosporine (data
not shown).
AC activity in membranes prepared from rat neutrophils
was increased by the addition of exogenous Ca2 +/CaM.
Chelation of Ca2 + by EDTA reversed the Ca2 +/CaM
stimulation (Fig. 4). The addition of exogenous PKC
catalytic fragment significantly increased the AC activity
(P < 0.01). The combination of the PKC catalytic fragment
with Ca2 +/CaM induced synergistic response, which was
attenuated by staurosporine. Six PKC-regulated AC iso-
forms have been reported: AC1, 2, 3, 4, 5 and 7 [29–32], of
which only AC1 and AC3 are synergistically stimulated by
Ca2 + and PKC activation [31,33]. These results are con-
sistent with those observed in intact cells and provided
Fig. 2. Time dependency of cyclic AMP accumulation in neutrophils. Cells
were incubated with DMSO, 0.1 AMA23187, 10 AM forskolin (FORS) or 1
AM isoproterenol (ISO) at 37 jC for the indicated time. Cellular cyclic
AMP levels was then determined. Values are meansF S.E. of five to seven
separate experiments.
Fig. 3. Effects of EDTA and trifluoperazine on A23187-stimulated cyclic
AMP accumulation in neutrophils. Cells were preincubated with DMSO, 1
mM EDTA or 20 AM trifluoperazine (TFP) at 37 jC for 10 min before
stimulation with 0.1 AM A23187 for 1 min or without stimulation, then
cellular cyclic AMP levels were determined. Values are meansF S.E. of
three to five separate experiments.
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further evidence to support the presence of group 1 AC
isoforms in rat neutrophils.
3.4. Group 2 AC isoforms activity
Addition of UK14304, the a2-adrenergic agonist, stimu-
lated cyclic AMP elevation (P < 0.01) in rat neutrophils.
This effect was prevented by PTX, the Gi/o inhibitor (Fig.
5). It is generally thought that the a2-adrenoceptors couple
with the heterotrimeric Gi/o proteins. Upon activation, this
catalyzes the exchange of GDP for GTP, with resultant
dissociation of GTP-Ga from the Ghg dimer. AC2, 4 and 7
are potently stimulated by Ghg [12,34,35]. The cytoplasmic
C2 domain of AC contains Ghg binding site [36]. Tsu et al.
[37] have demonstrated that the stimulation of AC2 by
chemoattractant formyl peptide (fMLP) is mediated via
PTX-sensitive Gi-like proteins. The increase in cyclic
AMP levels in response to UK14304 suggests the involve-
ment of group 2 AC isoforms in rat neutrophils. Previous
reports indicated that fMLP transiently increases intracellu-
lar cyclic AMP levels and enhances cyclic AMP accumu-
lation in response to the activation of Gs-coupled receptors
in neutrophils [25,38]. The potentiation by fMLP is abol-
ished by PTX. As expected, UK14304 enhanced the iso-
proterenol stimulation of cyclic AMP accumulation in rat
Fig. 5. Effects of UK14304 and PMA on isoproterenol-stimulated cyclic
AMP accumulation in neutrophils. Cells were incubated with DMSO, 10 AM
UK14304 (UK) or 1 AM PMA for 1 min before the addition, or no addition,
of 1 AM isoproterenol (ISO) at 37 jC for 10 min. In some experiments, cells
were preincubated with 1 Ag/ml of PTX for 1.5 h before the addition of
UK14304 at 37 jC for 10 min. The other cells were preincubated with PMA
for 1 min, then UK14304 was added for 1 min followed by isoproterenol at
37 jC for 10 min. Cellular cyclic AMP levels were then determined. Values
are meansF S.E. of five to eight separate experiments.
Fig. 4. Effects of Ca2 +/CaM and PKC on the AC activity of membrane
preparations from neutrophils. Membrane fractions were incubated with
DMSO, 1 mM EDTA, 100 nM staurosporine (STAU) or 30 ng/ml of PKC
catalytic fragment for 1 min before the addition, or no addition, of Ca2 +/
CaM (10:2.5 AM) at 37 jC for 10 min. In some experiments, membrane
fractions were preincubated with staurosporine for 1 min, then the PKC
catalytic fragment was added for 1 min followed by Ca2 +/CaM for 10 min.
The cyclic AMP levels were then determined. Values are meansF S.E. of
four to six separate experiments.
Fig. 6. Effects of forskolin, isoproterenol, GTPgS and Ghg on the AC
activity of membrane preparations from neutrophils. Membrane fractions
were incubated with DMSO, 10 AM forskolin (FORS), 50 AM GTPgS,
0.1 AM Ghg, 1 AM isoproterenol (ISO), forskolin plus GTPgS or iso-
proterenol plus Ghg at 37 jC for 10 min. The cyclic AMP levels were then
determined. Values are meansF S.E. of five to six separate experiments.
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neutrophils (Fig. 5). In rat lung alveolar type II cells, which
express AC2 and 4, UK14304 potentiated Gs-stimulated
cyclic AMP accumulation through PTX-sensitive release of
Ghg [39]. PKC has been reported to suppress the synergism
between Gsa and Ghg in the activation of AC2 and 4 [30].
Pretreatment with PMA attenuated the augmentation of
cyclic AMP levels in rat neutrophils in response to the
combination of UK14304 and isoproterenol (Fig. 5). These
results provide further evidence for the presence of group 2
AC isoforms.
The binding of GTPgS can stabilize the active confor-
mation of Ga, which activates the AC. Forskolin has been
suggested to bind to the site close to Gsa, which allows
forskolin to synergistically enhance Gsa activation [22].
Forskolin and Gsa activate AC2, 4, 5 and 6 synergistically
[10,40,41], while forskolin inhibits AC4 activity in the high
concentrations of Gsa [12]. In the membrane preparations
from rat neutrophils, forskolin attenuated the GTPgS stim-
ulation of AC activity (Fig. 6). This result is in accord with
those of Suzuki et al. [42], who found that forskolin
inhibited cyclic AMP formation stimulated by PGE1 in
guinea pig neutrophils and the GTPgS stimulation of AC
activity in the cell membrane. It is known that Ghg activates
AC2 and 4 in the presence of active Gsa [12,43]. In rat lung
alveolar type II cell membranes (containing AC2 and 4),
Ghg augmented the h-adrenoceptor agonist stimulation of
AC activity [39]. In the present study, Ghg also enhanced
the isoproterenol stimulation of AC activity in rat neutrophil
membrane (Fig. 6). Thus, our data, together with the other in
vivo and in vitro reports and the known distinct patterns of
the regulation of AC isoforms, suggest the contribution of
group 2 AC isoforms to the Gs-stimulated cyclic AMP
production in rat neutrophils.
3.5. Group 3 AC isoforms activity
Addition of isoproterenol to membrane fractions stimu-
lated cyclic AMP elevation as described above. This effect
was prevented by pretreatment of reaction mixture with the
activated PKA (Fig. 7). Gsa is not phosphorylated by PKA
and its activity is unaffected by PKA treatment [44]. It has
been reported that PKA directly phosphorylated and
inhibited AC5 and 6 activity [45,46]. Exposure to KT5720,
a PKA inhibitor, reversed the prevention of isoproterenol-
stimulated cyclic AMP elevation by the activated PKA (Fig.
7). The data imply the presence of group 3 isoforms in rat
neutrophils.
AC9 is widely distributed in tissues [15]. Calcineurin, a
Ca2 +/CaM-regulated protein phosphatase [47], acts as a
Ca2 + sensor that mediates the negative feedback effect of
intracellular Ca2 + on receptor-stimulated cyclic AMP pro-
duction of AC9 [48]. Whether AC9 activity is present in the
neutrophils awaits further investigation.
In summary, by utilizing RT-PCR analysis, we have
shown the presence of mRNA encoding for AC1 to AC9.
Whether the protein of AC isoforms is expressed to any
significant extent is not known yet because the antibodies
for specific AC isoforms are not available. The pharmaco-
logical evidence, together with the known biochemical
properties, confirmed the presence of groups 1, 2 and 3
AC activity in rat neutrophils.
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